"Medicare Expands Coverage to Include Wegovy for Cardiovascular Patients"

Medicare plans can now cover the weight-loss drug Wegovy for seniors with a history of cardiovascular disease, following the FDA's decision to broaden its approved use to include reducing the risk of heart failure. This marks a significant expansion of access to the drug for certain adults, although it generally won't be covered for weight management alone. The move by CMS could also put pressure on commercial insurers to cover the pricey drug, which has become a cultural sensation and blockbuster, but has faced challenges due to its high cost.